Search Result
Results for "
nanoparticles modification
" in MedChemExpress (MCE) Product Catalog:
161
Biochemical Assay Reagents
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-112764
-
|
|
Liposome
|
Metabolic Disease
|
|
DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
-
- HY-W011696
-
|
cis-1-Amino-9-octadecene, 80-90%
|
Environmental Pollutants
Biochemical Assay Reagents
|
Cancer
|
|
Oleylamine, 80-90% (cis-1-Amino-9-octadecene, 80-90%) is a multifunctional reagent used for metal ion coordination and nanoparticle surface modification, and acts as a solvent, surfactant and reducing agent in the synthesis of metal oxide nanoparticles. Oleylamine, 80-90% regulates nanoparticle morphology, magnetization intensity and water proton relaxation rate via thiol-ene "click" reaction, and enhances the colloidal stability of nanoparticles in organic reagents. Oleylamine, 80-90% is mainly used in research and applications in fields such as nanomaterial synthesis, biomedical imaging (MRI contrast agents, fluorescent probes), cancer cell targeting and drug delivery .
|
-
-
- HY-101530B
-
|
PEG 40 stearate
|
Biochemical Assay Reagents
|
Others
|
|
Polyoxyl 40 stearate (PEG 40 stearate) is a nonionic surfactant formed by the esterification of stearic acid with polyethylene glycol (PEG) containing approximately 40 ethoxy units, it is widely used in pharmaceutical preparations, nanodrug carriers, emulsification systems and biomedical materials. Polyoxyl 40 stearate can serve as a matrix component of solid lipid nanoparticles to achieve controlled release of encapsulated antifungal drugs; it can also act as a base material for solid lipid nanoparticles for vaginal administration, and polymerizable groups can be introduced via modification with acryloyl chloride .
|
-
-
- HY-P5533
-
|
|
Biochemical Assay Reagents
|
Cancer
|
|
CRT, an iron peptide mimic, can bind to apo-transferrin (apo-Tf). CRT can be used to modify nanoparticles, and enhances drug delivery efficiency .
|
-
-
- HY-W440813
-
|
|
Liposome
|
Others
|
|
Heptadecan-9-yl 8-bromooctanoate can be useful for the building or modification of lipid nanoparticles.
|
-
-
- HY-144013B
-
|
DSPE-mPEG550 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
|
18:0 mPEG550 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144013A
-
|
DSPE-mPEG350 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Liposome
|
Others
|
|
18:0 mPEG350 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144013D
-
|
DSPE-mPEG1000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
|
18:0 mPEG1000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144013E
-
|
DSPE-mPEG3000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
|
18:0 mPEG3000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144013C
-
|
DSPE-mPEG750 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
|
18:0 mPEG750 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155934
-
|
DOPE-PEG5000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Liposome
|
Others
|
|
18:1 PEG5000 PE ammonium (DOPE-PEG5000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155926
-
|
14:0 PEG750 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Liposome
|
Others
|
|
DMPE-PEG750 ammonium (14:0 PEG750 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155924
-
|
14:0 PEG350 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Liposome
|
Others
|
|
DMPE-PEG350 ammonium (14:0 PEG350 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155927
-
|
14:0 PEG1000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
|
DMPE-PEG1000 ammonium (14:0 PEG1000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155925
-
|
14:0 PEG550 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Liposome
|
Others
|
|
DMPE-PEG550 ammonium (14:0 PEG550 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155929
-
|
14:0 PEG5000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Liposome
|
Others
|
|
DMPE-PEG5000 ammonium (14:0 PEG5000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155928
-
|
14:0 PEG3000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
|
DMPE-PEG3000 ammonium (14:0 PEG3000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-112764GL
-
|
|
Liposome
|
Metabolic Disease
|
|
DMG-PEG 2000 (GMP Like) is DMG-PEG 2000 (HY-112764) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
-
- HY-144012B
-
|
16:0 PEG550 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
|
DPPE-PEG550 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144012C
-
|
16:0 PEG750 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
Liposome
|
Others
|
|
DPPE-PEG750 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144012E
-
|
16:0 PEG3000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
|
DPPE-PEG3000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-144012D
-
|
16:0 PEG1000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
|
DPPE-PEG1000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155931
-
|
DOPE-PEG550 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Liposome
|
Others
|
|
18:1 PEG550 PE ammonium (DOPE-PEG550 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155933
-
|
DOPE-PEG3000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Liposome
|
Others
|
|
18:1 PEG3000 PE ammonium (DOPE-PEG3000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155932
-
|
DOPE-PEG1000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Liposome
|
Others
|
|
18:1 PEG1000 PE ammonium (DOPE-PEG1000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-155930
-
|
DOPE-PEG350 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Liposome
|
Others
|
|
18:1 PEG350 PE ammonium (DOPE-PEG350 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
-
- HY-174358D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
HOOC-PEG10000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG10000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-116210
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Phenylphosphinic acid binds to metal oxide surfaces for a modification and functionalization. Phenylphosphinic acid can also be used for nanoparticles or sol-gel synthesis .
|
-
-
- HY-D2851B
-
|
|
Fluorescent Dye
|
Others
|
|
FITC-PEG5000-CHOL is a fluorescent dye composed of FITC (HY-66019), PEG and cholesterol. FITC-PEG5000-CHOL is widely used in cell membrane-related studies, liposome and nanoparticle modification, and biomolecule labeling (Ex/Em=488/525 nm) .
|
-
-
- HY-D2851
-
|
|
Fluorescent Dye
|
Others
|
|
FITC-PEG2000-CHOL is a fluorescent dye composed of FITC (HY-66019), PEG and cholesterol. FITC-PEG2000-CHOL is widely used in cell membrane-related studies, liposome and nanoparticle modification, and biomolecule labeling (Ex/Em=488/525 nm) .
|
-
-
- HY-174358E
-
|
|
Biochemical Assay Reagents
|
Others
|
|
HOOC-PEG20000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG20000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
-
- HY-153217
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Arsonic acid is a robust anchor group for the surface modification of Fe3O4. Arsonic acid binds strongly to the surface of iron oxide nanoparticles .
|
-
-
- HY-183164D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG10000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-183164
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG1000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-183164B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG3400-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-183164A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG2000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-183164C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG5000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-183175A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG2000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-183175
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG1000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-183175C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG5000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-183175B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG3400-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-183175D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG10000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
-
- HY-183170A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG2000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG2000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-183170C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG5000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG5000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-183170
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG1000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG1000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-183170B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG3400-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG3400-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-D2851A
-
|
|
Fluorescent Dye
|
Others
|
|
FITC-PEG-CHOL (MW 3400) is a fluorescent dye composed of FITC (HY-66019), PEG and cholesterol. FITC-PEG-CHOL (MW 5000) is widely used in cell membrane-related studies, liposome and nanoparticle modification, and biomolecule labeling (Ex/Em = 488/525 nm) .
|
-
-
- HY-182981A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG2000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-182981
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG1000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
-
- HY-182981B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG3400-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG5000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG10000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-200288B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG3400-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052117A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG3400-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052873C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052117
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG2000-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183173D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG10000-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-200288D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG10000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052873B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052873A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052117C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG1000-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183160
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG1000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-W1052051D
-
|
DPPE-PEG1000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-N3 (DPPE-PEG1000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183173C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG5000-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182836C
-
|
DMPE-PEG5000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG5000-N3 (DMPE-PEG5000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183173B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG3400-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051A
-
|
DPPE-PEG3400-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-N3 (DPPE-PEG3400-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051
-
|
DPPE-PEG2000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-N3 (DPPE-PEG2000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183173
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG1000-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182836A
-
|
DMPE-PEG2000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG2000-N3 (DMPE-PEG2000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183160B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG3400-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-W1052873D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183160A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG2000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-200288
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG2000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183173A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG2000-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182836
-
|
DMPE-PEG1000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG1000-N3 (DMPE-PEG1000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-182836B
-
|
DMPE-PEG3400-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG3400-N3 (DMPE-PEG3400-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-200288A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG1000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183160D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG10000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-W1052873
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051B
-
|
DPPE-PEG5000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-N3 (DPPE-PEG5000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052117D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG1000-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051C
-
|
DPPE-PEG10000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-N3 (DPPE-PEG10000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-200288C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMG-PEG5000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182836D
-
|
DMPE-PEG10000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG10000-N3 (DMPE-PEG10000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052117B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG5000-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183160C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG5000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-174358C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
HOOC-PEG5000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG5000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358
-
|
|
Biochemical Assay Reagents
|
Others
|
|
HOOC-PEG1000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG1000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-W1052492D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG10000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052492
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG2000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052227A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG3400-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG3400-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183126A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG2000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG2000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183126B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG3400-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG3400-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183126D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG10000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG10000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052227C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG1000-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052227B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG5000-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG5000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-174358H
-
|
|
Biochemical Assay Reagents
|
Others
|
|
HOOC-PEG40000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG40000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-W1052492C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052492B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG5000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052227D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG10000-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG10000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052492A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG3400-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-174358A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
HOOC-PEG2000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG2000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
HOOC-PEG3400-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG3400-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-183126C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG5000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG5000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052227
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG2000-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG2000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183126
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG1000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183003C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG5000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG5000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG1000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG10000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG2000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG2000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG10000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG1000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183003B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG3400-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183015B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Mannose-PEG3400-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183163D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG10000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182841D
-
|
DMPE-PEG10000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG10000-SH (DMPE-PEG10000-Thiol) is a conjugate composed of DMPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DMPE-PEG10000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-183163B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG3400-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183163
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG1000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182882D
-
|
DPPE-PEG10000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-SH (DPPE-PEG10000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG10000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-183163C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG5000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183055D
-
|
DSG-PEG10000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DSE-PEG10000-SH (DSE-PEG10000-Thiol) is a conjugate composed of DSE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DSE-PEG10000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182841C
-
|
DMPE-PEG5000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG5000-SH (DMPE-PEG5000-Thiol) is a conjugate composed of DMPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DMPE-PEG5000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-183055A
-
|
DSG-PEG2000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DSE-PEG2000-SH (DSE-PEG2000-Thiol) is a conjugate composed of DSE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DSE-PEG2000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182882A
-
|
DPPE-PEG2000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-SH (DPPE-PEG2000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG2000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-183055B
-
|
DSG-PEG3400-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DSE-PEG3400-SH (DSE-PEG3400-Thiol) is a conjugate composed of DSE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DSE-PEG3400-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-183163A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG2000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182882C
-
|
DPPE-PEG5000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-SH (DPPE-PEG5000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG5000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182882
-
|
DPPE-PEG1000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-SH (DPPE-PEG1000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG1000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-183055
-
|
DSG-PEG1000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DSE-PEG1000-SH (DSE-PEG1000-Thiol) is a conjugate composed of DSE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DSE-PEG1000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182841
-
|
DMPE-PEG1000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG1000-SH (DMPE-PEG1000-Thiol) is a conjugate composed of DMPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DMPE-PEG1000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182882B
-
|
DPPE-PEG3400-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-SH (DPPE-PEG3400-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG3400-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-182841A
-
|
DMPE-PEG2000-Thiol
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG2000-SH (DMPE-PEG2000-Thiol) is a conjugate composed of DMPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DMPE-PEG2000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG1000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG5000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG2000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG10000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052523A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG3400-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-182833A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG2000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG10000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG10000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG3400-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG3400-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183104D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG10000-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG10000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183104
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG1000-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG1000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183016
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG1000-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG1000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183104B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG3400-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG3400-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183104A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG2000-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183016C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG5000-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG5000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183016B
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG3400-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG3400-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG1000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG1000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183104C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DSG-PEG5000-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG5000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-182833C
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DPPE-PEG5000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG5000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183016A
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG2000-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-183016D
-
|
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG10000-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG10000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1053112B
-
|
DOPE-PEG10000-NH2
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-PEG10000-Amine (DOPE-PEG1000-NH2) is a conjugate composed of dioleoylphosphatidylethanolamine (DOPE), a PEG chain, and a terminal amino group (-NH2). The amino group in DOPE-PEG10000-Amine can chemically react with carboxyl groups, activated esters, etc., participating in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-W440990
-
|
DOPE-PEG1000-NH2
|
Biochemical Assay Reagents
|
Others
|
|
DOPE-PEG1000-Amine (DOPE-PEG1000-NH2) is a conjugate composed of dioleoylphosphatidylethanolamine (DOPE), a PEG chain, and a terminal amino group (-NH2). The amino group in DOPE-PEG1000-Amine can chemically react with carboxyl groups, activated esters, etc., participating in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052298
-
|
DMPE-PEG2000-Amine
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG2000-NH2 (DMPE-PEG2000-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG2000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052298B
-
|
DMPE-PEG5000-Amine
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG5000-NH2 (DMPE-PEG5000-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG5000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052298D
-
|
DMPE-PEG10000-Amine
|
Biochemical Assay Reagents
|
|
|
DMPE-PEG2000-NH2 (DMPE-PEG2000-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG2000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052298A
-
|
DMPE-PEG3400-Amine
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG3400-NH2 (DMPE-PEG3400-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG3400-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052298C
-
|
DMPE-PEG1000-Amine
|
Biochemical Assay Reagents
|
Others
|
|
DMPE-PEG1000-NH2 (DMPE-PEG1000-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG1000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
-
- HY-183161
-
|
Glucose-PEG1000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG1000-N3 (Glucose-PEG1000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG1000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161C
-
|
Glucose-PEG5000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG5000-N3 (Glucose-PEG5000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG5000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-185404
-
|
|
Drug Intermediate
|
Others
|
|
DSPE-PEG8-OH is a monodisperse lipid-polyethylene glycol conjugate featuring a hydrophobic 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) anchor, an 8-unit discrete (PEG8) spacer, and a terminal hydroxyl (-OH) group. DSPE-PEG8-OH is primarily used in liposome formulation, nanoparticle surface modification, and targeted drug delivery systems.
|
-
- HY-183161D
-
|
Glucose-PEG10000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG10000-N3 (Glucose-PEG10000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG10000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161A
-
|
Glucose-PEG2000-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG2000-N3 (Glucose-PEG2000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG2000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161B
-
|
Glucose-PEG3400-Azide
|
Biochemical Assay Reagents
|
Others
|
|
Glucose-PEG3400-N3 (Glucose-PEG3400-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG3400-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-155882
-
|
mPEG750-NH2
|
Biochemical Assay Reagents
|
Cancer
|
|
mPEG750-amine (mPEG750-NH2) is a chemical modification reagent for nanoparticles, capable of covalently binding to Ad-PVA to form Ad-PVA-PEG polymers. mPEG750-amine stabilizes gene delivery complexes by providing steric hindrance, reducing particle aggregation, while enhancing the water solubility and serum stability of the complex, reducing carrier cytotoxicity, and assisting in the efficient condensation of pDNA by cationic components to form nanoparticles that can be endocytosed by cells. mPEG750-amine can also be used to synthesize folate-conjugated polymer micelles for encapsulating the anticancer agent Camptothecin (HY-16560). Folate-conjugated polymer micelles are effective carriers for poorly soluble anticancer drugs, capable of avoiding macrophages and acting through folate receptor (FR)-mediated endocytosis to target tumor cells. mPEG750-amine can be applied to research in the field of non-viral gene delivery, as a component of gene delivery vectors, facilitating the safe and efficient delivery of nucleic acid drugs to target cells .
|
-
- HY-W012166
-
|
NHS-Bromoacetate
|
Biochemical Assay Reagents
|
Infection
|
|
N-Succinimidyl bromoacetate (NHS-Bromoacetate) is a heterobifunctional crosslinking reagent, mainly used to modify the ɛ-amino group of lysine side chains. By covalently linking its bromoacetyl moiety to the ɛ-amino group of lysine in peptidomimetics, N-Succinimidyl bromoacetate enables their conjugation with thiol-modified nanoparticles via thioether bonds. N-Succinimidyl bromoacetate also performs bromoacetylation modification on carrier proteins, which then forms stable thioether bonds with the thiol groups of cysteine in peptides, thus efficiently preparing soluble peptide-protein conjugates with high substitution ratios. N-Succinimidyl bromoacetate can be used to prepare activated Sepharose derivatives for affinity chromatography, protein affinity labeling reagents, and peptide-protein immunogen conjugates with non-immunogenic linkages. N-Succinimidyl bromoacetate is applicable to studies related to HIV-1 infection and glioblastoma multiforme .
|
-
| Cat. No. |
Product Name |
Type |
-
- HY-112764GL
-
|
|
Fluorescent Dyes
|
|
DMG-PEG 2000 (GMP Like) is DMG-PEG 2000 (HY-112764) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-D2851B
-
|
|
Fluorescent Dyes
|
|
FITC-PEG5000-CHOL is a fluorescent dye composed of FITC (HY-66019), PEG and cholesterol. FITC-PEG5000-CHOL is widely used in cell membrane-related studies, liposome and nanoparticle modification, and biomolecule labeling (Ex/Em=488/525 nm) .
|
-
- HY-D2851
-
|
|
Fluorescent Dyes
|
|
FITC-PEG2000-CHOL is a fluorescent dye composed of FITC (HY-66019), PEG and cholesterol. FITC-PEG2000-CHOL is widely used in cell membrane-related studies, liposome and nanoparticle modification, and biomolecule labeling (Ex/Em=488/525 nm) .
|
-
- HY-D2851A
-
|
|
Fluorescent Dyes
|
|
FITC-PEG-CHOL (MW 3400) is a fluorescent dye composed of FITC (HY-66019), PEG and cholesterol. FITC-PEG-CHOL (MW 5000) is widely used in cell membrane-related studies, liposome and nanoparticle modification, and biomolecule labeling (Ex/Em = 488/525 nm) .
|
| Cat. No. |
Product Name |
Type |
-
- HY-112764
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-W011696
-
|
cis-1-Amino-9-octadecene, 80-90%
|
Biochemical Assay Reagents
|
|
Oleylamine, 80-90% (cis-1-Amino-9-octadecene, 80-90%) is a multifunctional reagent used for metal ion coordination and nanoparticle surface modification, and acts as a solvent, surfactant and reducing agent in the synthesis of metal oxide nanoparticles. Oleylamine, 80-90% regulates nanoparticle morphology, magnetization intensity and water proton relaxation rate via thiol-ene "click" reaction, and enhances the colloidal stability of nanoparticles in organic reagents. Oleylamine, 80-90% is mainly used in research and applications in fields such as nanomaterial synthesis, biomedical imaging (MRI contrast agents, fluorescent probes), cancer cell targeting and drug delivery .
|
-
- HY-W440813
-
|
|
Biochemical Assay Reagents
|
|
Heptadecan-9-yl 8-bromooctanoate can be useful for the building or modification of lipid nanoparticles.
|
-
- HY-144013B
-
|
DSPE-mPEG550 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
|
|
18:0 mPEG550 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013A
-
|
DSPE-mPEG350 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Biochemical Assay Reagents
|
|
18:0 mPEG350 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013D
-
|
DSPE-mPEG1000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Biochemical Assay Reagents
|
|
18:0 mPEG1000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013E
-
|
DSPE-mPEG3000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Biochemical Assay Reagents
|
|
18:0 mPEG3000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013C
-
|
DSPE-mPEG750 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
|
|
18:0 mPEG750 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155934
-
|
DOPE-PEG5000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Biochemical Assay Reagents
|
|
18:1 PEG5000 PE ammonium (DOPE-PEG5000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155926
-
|
14:0 PEG750 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
|
|
DMPE-PEG750 ammonium (14:0 PEG750 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155924
-
|
14:0 PEG350 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Biochemical Assay Reagents
|
|
DMPE-PEG350 ammonium (14:0 PEG350 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155927
-
|
14:0 PEG1000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Biochemical Assay Reagents
|
|
DMPE-PEG1000 ammonium (14:0 PEG1000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155925
-
|
14:0 PEG550 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
|
|
DMPE-PEG550 ammonium (14:0 PEG550 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155929
-
|
14:0 PEG5000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
Biochemical Assay Reagents
|
|
DMPE-PEG5000 ammonium (14:0 PEG5000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155928
-
|
14:0 PEG3000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Biochemical Assay Reagents
|
|
DMPE-PEG3000 ammonium (14:0 PEG3000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-112764GL
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG 2000 (GMP Like) is DMG-PEG 2000 (HY-112764) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-144012B
-
|
16:0 PEG550 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG550 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012C
-
|
16:0 PEG750 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG750 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012E
-
|
16:0 PEG3000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG3000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012D
-
|
16:0 PEG1000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155931
-
|
DOPE-PEG550 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
Biochemical Assay Reagents
|
|
18:1 PEG550 PE ammonium (DOPE-PEG550 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155933
-
|
DOPE-PEG3000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
Biochemical Assay Reagents
|
|
18:1 PEG3000 PE ammonium (DOPE-PEG3000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155932
-
|
DOPE-PEG1000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
Biochemical Assay Reagents
|
|
18:1 PEG1000 PE ammonium (DOPE-PEG1000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155930
-
|
DOPE-PEG350 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
Biochemical Assay Reagents
|
|
18:1 PEG350 PE ammonium (DOPE-PEG350 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-174358D
-
|
|
Biochemical Assay Reagents
|
|
HOOC-PEG10000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG10000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358A
-
|
|
Biochemical Assay Reagents
|
|
HOOC-PEG2000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG2000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-174358E
-
|
|
Biochemical Assay Reagents
|
|
HOOC-PEG20000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG20000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
-
- HY-183164D
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG10000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183164
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG1000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183164B
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG3400-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183164A
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG2000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183164C
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-OH is a conjugate composed of glucose, PEG chains, and hydroxyl groups (-OH). Glucose-PEG5000-OH combines the targeted recognition capability of glucose with the modification flexibility of hydroxyl groups, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183175A
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG2000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183175
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG1000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183175C
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG5000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183175B
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG3400-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183175D
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG10000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183170A
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG2000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG2000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183170C
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG5000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG5000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183170
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG1000-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG1000-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183170B
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG3400-Biotin is a conjugate composed of DSG, PEG chains, and biotin. DSG-PEG3400-Biotin combines the membrane compatibility of phospholipids with the high affinity of biotin for avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981A
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG2000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG1000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981B
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG3400-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981C
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG5000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-182981D
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG10000-Biotin is a conjugate composed of mannose, PEG chains, and biotin. Mannose-PEG-Biotin combines the targeting recognition ability of mannose with the high affinity of biotin to bind avidin/link avidin, and is used for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-200288B
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG3400-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052117A
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG3400-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052873C
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052117
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG2000-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183173D
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG10000-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-200288D
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG10000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052873B
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052873A
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052117C
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG1000-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183160
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG1000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-W1052051D
-
|
DPPE-PEG1000-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-N3 (DPPE-PEG1000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-183173C
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG5000-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-182836C
-
|
DMPE-PEG5000-Azide
|
Biochemical Assay Reagents
|
|
DMPE-PEG5000-N3 (DMPE-PEG5000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-183173B
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG3400-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG3400-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052051A
-
|
DPPE-PEG3400-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-N3 (DPPE-PEG3400-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-W1052051
-
|
DPPE-PEG2000-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-N3 (DPPE-PEG2000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-183173
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG1000-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-182836A
-
|
DMPE-PEG2000-Azide
|
Biochemical Assay Reagents
|
|
DMPE-PEG2000-N3 (DMPE-PEG2000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-183160B
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG3400-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-W1052873D
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG10000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183160A
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG2000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-200288
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG2000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183173A
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG2000-COOH is a conjugate composed of DSG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DSG-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-182836
-
|
DMPE-PEG1000-Azide
|
Biochemical Assay Reagents
|
|
DMPE-PEG1000-N3 (DMPE-PEG1000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-182836B
-
|
DMPE-PEG3400-Azide
|
Biochemical Assay Reagents
|
|
DMPE-PEG3400-N3 (DMPE-PEG3400-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-200288A
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG1000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183160D
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG10000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-W1052873
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-COOH is a conjugate composed of DPPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DPPE-PEG2000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052051B
-
|
DPPE-PEG5000-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-N3 (DPPE-PEG5000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-W1052117D
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG1000-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG1000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052051C
-
|
DPPE-PEG10000-Azide
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-N3 (DPPE-PEG10000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-200288C
-
|
|
Biochemical Assay Reagents
|
|
DMG-PEG5000-COOH is a conjugate composed of DMG, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMG-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-182836D
-
|
DMPE-PEG10000-Azide
|
Biochemical Assay Reagents
|
|
DMPE-PEG10000-N3 (DMPE-PEG10000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
- HY-W1052117B
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG5000-COOH is a conjugate composed of DMPE, a PEG chain, and a terminal carboxyl group (-COOH). The carboxyl group in DMPE-PEG5000-COOH can form an amide bond with a primary amine via EDC/NHS activation, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183160C
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-Biotin is a conjugate composed of glucose, PEG chains, and biotin. Glucose-PEG5000-Biotin combines the targeted recognition capabilities of glucose with the high-affinity binding ability of biotin to avidin/streptavidin, enabling applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-174358C
-
|
|
Biochemical Assay Reagents
|
|
HOOC-PEG5000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG5000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
- HY-174358
-
|
|
Biochemical Assay Reagents
|
|
HOOC-PEG1000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG1000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
- HY-W1052492D
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG10000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052492
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG2000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052227A
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG3400-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG3400-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-183126A
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG2000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG2000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-183126B
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG3400-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG3400-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-183126D
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG10000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG10000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052227C
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG1000-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052227B
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG5000-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG5000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-174358H
-
|
|
Biochemical Assay Reagents
|
|
HOOC-PEG40000-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG40000-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
- HY-W1052492C
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052492B
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG5000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052227D
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG10000-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG10000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052492A
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-Mal is a conjugate composed of DPPE, PEG chains, and maleimide (Mal). The maleimide group in DPPE-PEG3400-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-174358B
-
|
|
Biochemical Assay Reagents
|
|
HOOC-PEG3400-COOH has two active carboxyl groups at both ends, which can selectively react with the amino groups in peptide coupling agents. HOOC-PEG3400-COOH is a good cross-linking agent for PEGylation of proteins and peptides, nanoparticles and surface modification .
|
- HY-183126C
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG5000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG5000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1052227
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG2000-Mal is a conjugate composed of DMPE, PEG chains, and maleimide (Mal). The maleimide group in DMPE-PEG2000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-183126
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG1000-Mal is a conjugate composed of DSG, PEG chains, and maleimide (Mal). The maleimide group in DSG-PEG1000-Mal can undergo a specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), enabling targeted modification of liposomes/nanoparticles.
|
- HY-183003C
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG5000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015C
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG5000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG1000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003D
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG10000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015A
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG2000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003A
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG2000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015D
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG10000-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG1000-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183003B
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG3400-COOH is a conjugate composed of mannose, PEG chains, and carboxyl groups (COOH). Mannose-PEG-COOH combines the targeting recognition ability of mannose with the carboxyl group, which can undergo condensation or esterification reactions with amino and hydroxyl groups, for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183015B
-
|
|
Biochemical Assay Reagents
|
|
Mannose-PEG3400-NH2 is composed of mannose, PEG chains, and terminal amino groups (–NH2). Mannose-PEG-NH2 combines the targeting recognition ability of mannose with the chemical modifiability of amino groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183163D
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG10000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-182841D
-
|
DMPE-PEG10000-Thiol
|
Biochemical Assay Reagents
|
|
DMPE-PEG10000-SH (DMPE-PEG10000-Thiol) is a conjugate composed of DMPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DMPE-PEG10000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-183163B
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG3400-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183163
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG1000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-182882D
-
|
DPPE-PEG10000-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-SH (DPPE-PEG10000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG10000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-183163C
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG5000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-183055D
-
|
DSG-PEG10000-Thiol
|
Biochemical Assay Reagents
|
|
DSE-PEG10000-SH (DSE-PEG10000-Thiol) is a conjugate composed of DSE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DSE-PEG10000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-182841C
-
|
DMPE-PEG5000-Thiol
|
Biochemical Assay Reagents
|
|
DMPE-PEG5000-SH (DMPE-PEG5000-Thiol) is a conjugate composed of DMPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DMPE-PEG5000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-183055A
-
|
DSG-PEG2000-Thiol
|
Biochemical Assay Reagents
|
|
DSE-PEG2000-SH (DSE-PEG2000-Thiol) is a conjugate composed of DSE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DSE-PEG2000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-182882A
-
|
DPPE-PEG2000-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-SH (DPPE-PEG2000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG2000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-183055B
-
|
DSG-PEG3400-Thiol
|
Biochemical Assay Reagents
|
|
DSE-PEG3400-SH (DSE-PEG3400-Thiol) is a conjugate composed of DSE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DSE-PEG3400-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-183163A
-
|
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-COOH is a conjugate composed of glucose, PEG chains, and carboxyl groups (COOH). Glucose-PEG2000-COOH combines the targeting recognition ability of glucose with the carboxyl groups capable of condensation or esterification reactions with amino and hydroxyl groups, making it suitable for applications such as targeted drug delivery systems and nanoparticle modification.
|
- HY-182882C
-
|
DPPE-PEG5000-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-SH (DPPE-PEG5000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG5000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-182882
-
|
DPPE-PEG1000-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-SH (DPPE-PEG1000-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG1000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-183055
-
|
DSG-PEG1000-Thiol
|
Biochemical Assay Reagents
|
|
DSE-PEG1000-SH (DSE-PEG1000-Thiol) is a conjugate composed of DSE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DSE-PEG1000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-182841
-
|
DMPE-PEG1000-Thiol
|
Biochemical Assay Reagents
|
|
DMPE-PEG1000-SH (DMPE-PEG1000-Thiol) is a conjugate composed of DMPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DMPE-PEG1000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-182882B
-
|
DPPE-PEG3400-Thiol
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-SH (DPPE-PEG3400-Thiol) is a conjugate composed of DPPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DPPE-PEG3400-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-182841A
-
|
DMPE-PEG2000-Thiol
|
Biochemical Assay Reagents
|
|
DMPE-PEG2000-SH (DMPE-PEG2000-Thiol) is a conjugate composed of DMPE, a PEG chain, and a terminal thiol group (-SH). The thiol group in DMPE-PEG2000-SH exhibits strong chemical reactivity and can participate in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-W1052523C
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG1000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-W1052523B
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG5000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-W1052523
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG2000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-W1052523D
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG10000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-W1052523A
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-NH2 is a conjugate composed of DPPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DPPE-PEG3400-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-182833A
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG2000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-182833D
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG10000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG10000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-182833B
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG3400-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG3400-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183104D
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG10000-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG10000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183104
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG1000-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG1000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183016
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG1000-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG1000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183104B
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG3400-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG3400-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183104A
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG2000-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183016C
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG5000-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG5000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183016B
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG3400-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG3400-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-182833
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG1000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG1000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183104C
-
|
|
Biochemical Assay Reagents
|
|
DSG-PEG5000-NHS is a conjugate composed of DSG, PEG chains, and terminal active esters (NHS). The NHS ester in DSG-PEG5000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-182833C
-
|
|
Biochemical Assay Reagents
|
|
DPPE-PEG5000-NHS is a conjugate composed of DPPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG5000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183016A
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG2000-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG2000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-183016D
-
|
|
Biochemical Assay Reagents
|
|
DMPE-PEG10000-NHS is a conjugate composed of DMPE, PEG chains, and terminal active esters (NHS). The NHS ester in DMPE-PEG10000-NHS can rapidly covalently react with molecules containing primary amines (such as proteins, peptides, and small molecules modified with amino groups) to form stable amide bonds, enabling targeted modification of liposomes/nanoparticles.
|
- HY-W1053112B
-
|
DOPE-PEG10000-NH2
|
Biochemical Assay Reagents
|
|
DOPE-PEG10000-Amine (DOPE-PEG1000-NH2) is a conjugate composed of dioleoylphosphatidylethanolamine (DOPE), a PEG chain, and a terminal amino group (-NH2). The amino group in DOPE-PEG10000-Amine can chemically react with carboxyl groups, activated esters, etc., participating in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-W440990
-
|
DOPE-PEG1000-NH2
|
Biochemical Assay Reagents
|
|
DOPE-PEG1000-Amine (DOPE-PEG1000-NH2) is a conjugate composed of dioleoylphosphatidylethanolamine (DOPE), a PEG chain, and a terminal amino group (-NH2). The amino group in DOPE-PEG1000-Amine can chemically react with carboxyl groups, activated esters, etc., participating in various bioconjugation reactions for targeted modification of liposomes/nanoparticles.
|
- HY-W1052298
-
|
DMPE-PEG2000-Amine
|
Biochemical Assay Reagents
|
|
DMPE-PEG2000-NH2 (DMPE-PEG2000-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG2000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-W1052298B
-
|
DMPE-PEG5000-Amine
|
Biochemical Assay Reagents
|
|
DMPE-PEG5000-NH2 (DMPE-PEG5000-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG5000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-W1052298D
-
|
DMPE-PEG10000-Amine
|
Biochemical Assay Reagents
|
|
DMPE-PEG2000-NH2 (DMPE-PEG2000-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG2000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-W1052298A
-
|
DMPE-PEG3400-Amine
|
Biochemical Assay Reagents
|
|
DMPE-PEG3400-NH2 (DMPE-PEG3400-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG3400-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-W1052298C
-
|
DMPE-PEG1000-Amine
|
Biochemical Assay Reagents
|
|
DMPE-PEG1000-NH2 (DMPE-PEG1000-Amine) is a conjugate composed of DMPE, a PEG chain, and a terminal primary amino group (-NH2). The primary amino group in DMPE-PEG1000-NH2 can be covalently linked to functional groups such as carboxylic acids, NHS esters, and isocyanates for targeted modification of liposomes/nanoparticles.
|
- HY-183161
-
|
Glucose-PEG1000-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG1000-N3 (Glucose-PEG1000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG1000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-183161C
-
|
Glucose-PEG5000-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG5000-N3 (Glucose-PEG5000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG5000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-183161D
-
|
Glucose-PEG10000-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG10000-N3 (Glucose-PEG10000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG10000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-183161A
-
|
Glucose-PEG2000-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG2000-N3 (Glucose-PEG2000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG2000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-183161B
-
|
Glucose-PEG3400-Azide
|
Biochemical Assay Reagents
|
|
Glucose-PEG3400-N3 (Glucose-PEG3400-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG3400-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
- HY-155882
-
|
mPEG750-NH2
|
Biochemical Assay Reagents
|
|
mPEG750-amine (mPEG750-NH2) is a chemical modification reagent for nanoparticles, capable of covalently binding to Ad-PVA to form Ad-PVA-PEG polymers. mPEG750-amine stabilizes gene delivery complexes by providing steric hindrance, reducing particle aggregation, while enhancing the water solubility and serum stability of the complex, reducing carrier cytotoxicity, and assisting in the efficient condensation of pDNA by cationic components to form nanoparticles that can be endocytosed by cells. mPEG750-amine can also be used to synthesize folate-conjugated polymer micelles for encapsulating the anticancer agent Camptothecin (HY-16560). Folate-conjugated polymer micelles are effective carriers for poorly soluble anticancer drugs, capable of avoiding macrophages and acting through folate receptor (FR)-mediated endocytosis to target tumor cells. mPEG750-amine can be applied to research in the field of non-viral gene delivery, as a component of gene delivery vectors, facilitating the safe and efficient delivery of nucleic acid drugs to target cells .
|
| Cat. No. |
Product Name |
Target |
Research Area |
| Cat. No. |
Product Name |
|
Classification |
-
- HY-183175A
-
|
|
|
Azide
|
|
DSG-PEG2000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183175
-
|
|
|
Azide
|
|
DSG-PEG1000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183175C
-
|
|
|
Azide
|
|
DSG-PEG5000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183175B
-
|
|
|
Azide
|
|
DSG-PEG3400-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183175D
-
|
|
|
Azide
|
|
DSG-PEG10000-N3 is a conjugate composed of DSG, PEG chains, and terminal azido groups (-N3). DSG-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051D
-
|
DPPE-PEG1000-Azide
|
|
Azide
|
|
DPPE-PEG1000-N3 (DPPE-PEG1000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-182836C
-
|
DMPE-PEG5000-Azide
|
|
Azide
|
|
DMPE-PEG5000-N3 (DMPE-PEG5000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051A
-
|
DPPE-PEG3400-Azide
|
|
Azide
|
|
DPPE-PEG3400-N3 (DPPE-PEG3400-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051
-
|
DPPE-PEG2000-Azide
|
|
Azide
|
|
DPPE-PEG2000-N3 (DPPE-PEG2000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-182836A
-
|
DMPE-PEG2000-Azide
|
|
Azide
|
|
DMPE-PEG2000-N3 (DMPE-PEG2000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG2000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-182836
-
|
DMPE-PEG1000-Azide
|
|
Azide
|
|
DMPE-PEG1000-N3 (DMPE-PEG1000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG1000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-182836B
-
|
DMPE-PEG3400-Azide
|
|
Azide
|
|
DMPE-PEG3400-N3 (DMPE-PEG3400-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG3400-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051B
-
|
DPPE-PEG5000-Azide
|
|
Azide
|
|
DPPE-PEG5000-N3 (DPPE-PEG5000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG5000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-W1052051C
-
|
DPPE-PEG10000-Azide
|
|
Azide
|
|
DPPE-PEG10000-N3 (DPPE-PEG10000-Azide) is a conjugate composed of DPPE, PEG chains, and terminal azido groups (-N3). DPPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-182836D
-
|
DMPE-PEG10000-Azide
|
|
Azide
|
|
DMPE-PEG10000-N3 (DMPE-PEG10000-Azide) is a conjugate composed of DMPE, PEG chains, and terminal azido groups (-N3). DMPE-PEG10000-Azide is a click chemistry reagent used for the targeted modification of liposomes/nanoparticles.
|
-
- HY-183161
-
|
Glucose-PEG1000-Azide
|
|
Azide
|
|
Glucose-PEG1000-N3 (Glucose-PEG1000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG1000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161C
-
|
Glucose-PEG5000-Azide
|
|
Azide
|
|
Glucose-PEG5000-N3 (Glucose-PEG5000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG5000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161D
-
|
Glucose-PEG10000-Azide
|
|
Azide
|
|
Glucose-PEG10000-N3 (Glucose-PEG10000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG10000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161A
-
|
Glucose-PEG2000-Azide
|
|
Azide
|
|
Glucose-PEG2000-N3 (Glucose-PEG2000-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG2000-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
-
- HY-183161B
-
|
Glucose-PEG3400-Azide
|
|
Azide
|
|
Glucose-PEG3400-N3 (Glucose-PEG3400-Azide) is a conjugate composed of glucose, PEG chains, and an azide group (-N3). Glucose-PEG3400-N3 combines the targeted recognition ability of glucose with the azide group that can undergo click chemistry, making it suitable for applications such as constructing targeted drug delivery systems and nanoparticle modification.
|
| Cat. No. |
Product Name |
|
Classification |
-
- HY-112764
-
|
|
|
Pegylated Lipids
|
|
DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
- HY-155882
-
|
mPEG750-NH2
|
|
Polymers
|
|
mPEG750-amine (mPEG750-NH2) is a chemical modification reagent for nanoparticles, capable of covalently binding to Ad-PVA to form Ad-PVA-PEG polymers. mPEG750-amine stabilizes gene delivery complexes by providing steric hindrance, reducing particle aggregation, while enhancing the water solubility and serum stability of the complex, reducing carrier cytotoxicity, and assisting in the efficient condensation of pDNA by cationic components to form nanoparticles that can be endocytosed by cells. mPEG750-amine can also be used to synthesize folate-conjugated polymer micelles for encapsulating the anticancer agent Camptothecin (HY-16560). Folate-conjugated polymer micelles are effective carriers for poorly soluble anticancer drugs, capable of avoiding macrophages and acting through folate receptor (FR)-mediated endocytosis to target tumor cells. mPEG750-amine can be applied to research in the field of non-viral gene delivery, as a component of gene delivery vectors, facilitating the safe and efficient delivery of nucleic acid drugs to target cells .
|
-
- HY-101530B
-
|
PEG 40 stearate
|
|
Emulsifiers
Bases
Solubilizing Agents
|
|
Polyoxyl 40 stearate (PEG 40 stearate) is a nonionic surfactant formed by the esterification of stearic acid with polyethylene glycol (PEG) containing approximately 40 ethoxy units, it is widely used in pharmaceutical preparations, nanodrug carriers, emulsification systems and biomedical materials. Polyoxyl 40 stearate can serve as a matrix component of solid lipid nanoparticles to achieve controlled release of encapsulated antifungal drugs; it can also act as a base material for solid lipid nanoparticles for vaginal administration, and polymerizable groups can be introduced via modification with acryloyl chloride .
|
-
- HY-144013B
-
|
DSPE-mPEG550 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
|
Pegylated Lipids
|
|
18:0 mPEG550 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013A
-
|
DSPE-mPEG350 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
|
Pegylated Lipids
|
|
18:0 mPEG350 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013D
-
|
DSPE-mPEG1000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
|
Pegylated Lipids
|
|
18:0 mPEG1000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013E
-
|
DSPE-mPEG3000 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
|
Pegylated Lipids
|
|
18:0 mPEG3000 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144013C
-
|
DSPE-mPEG750 ammonium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
|
Pegylated Lipids
|
|
18:0 mPEG750 PE (ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155934
-
|
DOPE-PEG5000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
|
Pegylated Lipids
|
|
18:1 PEG5000 PE ammonium (DOPE-PEG5000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155926
-
|
14:0 PEG750 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
|
Pegylated Lipids
|
|
DMPE-PEG750 ammonium (14:0 PEG750 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155924
-
|
14:0 PEG350 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
|
Pegylated Lipids
|
|
DMPE-PEG350 ammonium (14:0 PEG350 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155927
-
|
14:0 PEG1000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
|
Pegylated Lipids
|
|
DMPE-PEG1000 ammonium (14:0 PEG1000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155925
-
|
14:0 PEG550 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
|
Pegylated Lipids
|
|
DMPE-PEG550 ammonium (14:0 PEG550 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymeric nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155929
-
|
14:0 PEG5000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] ammonium
|
|
Pegylated Lipids
|
|
DMPE-PEG5000 ammonium (14:0 PEG5000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155928
-
|
14:0 PEG3000 PE ammonium; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
|
Pegylated Lipids
|
|
DMPE-PEG3000 ammonium (14:0 PEG3000 PE ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012B
-
|
16:0 PEG550 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG550 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012C
-
|
16:0 PEG750 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-750] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG750 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012E
-
|
16:0 PEG3000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG3000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-144012D
-
|
16:0 PEG1000 PE; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
|
Pegylated Lipids
|
|
DPPE-PEG1000 is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155931
-
|
DOPE-PEG550 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-550] ammonium
|
|
Pegylated Lipids
|
|
18:1 PEG550 PE ammonium (DOPE-PEG550 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155933
-
|
DOPE-PEG3000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-3000] ammonium
|
|
Pegylated Lipids
|
|
18:1 PEG3000 PE ammonium (DOPE-PEG3000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155932
-
|
DOPE-PEG1000 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-1000] ammonium
|
|
Pegylated Lipids
|
|
18:1 PEG1000 PE ammonium (DOPE-PEG1000 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
-
- HY-155930
-
|
DOPE-PEG350 ammonium; 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-350] ammonium
|
|
Pegylated Lipids
|
|
18:1 PEG350 PE ammonium (DOPE-PEG350 ammonium) is a PEG lipid functional end group used in the synthesis of liposomes (LPs) for the design of conjugated polymer nanoparticles. Through biotin modification and carboxyl terminus, lipid nanoparticles (LNPs) further coupling with other biomolecules can be achieved. Functionalized nanoparticles can be used for targeted labeling of specific cellular proteins. With streptavidin as a linker, biotinylated PEG lipid-conjugated polymer nanoparticles are able to bind to biotinylated antibodies on cell surface receptors, yielding the utility of fluorescence-based imaging and sensing.
|
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-112764GL
-
|
|
Liposome
|
Metabolic Disease
|
|
DMG-PEG 2000 (GMP Like) is DMG-PEG 2000 (HY-112764) produced by using GMP like guidelines. GMP Like small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
|
-
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent:
